A Randomized, Open Label, Multicenter, Phase 4 Study for the Comparison of Efficacy of Tiotropium Plus Salmeterol/ Fluticasone Propionate Compared With Tiotropium Alone in COPD Patients.

Trial Profile

A Randomized, Open Label, Multicenter, Phase 4 Study for the Comparison of Efficacy of Tiotropium Plus Salmeterol/ Fluticasone Propionate Compared With Tiotropium Alone in COPD Patients.

Completed
Phase of Trial: Phase IV

Latest Information Update: 01 Apr 2010

At a glance

  • Drugs Salmeterol/fluticasone propionate; Tiotropium bromide
  • Indications Chronic obstructive pulmonary disease
  • Focus Therapeutic Use
  • Most Recent Events

    • 01 Apr 2010 Actual end date (Mar 2010) added as reported by ClinicalTrials.gov.
    • 01 Apr 2010 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
    • 01 Apr 2010 Actual patient number (509) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top